GDF15 antibody (N-Term)
-
- Target See all GDF15 Antibodies
- GDF15 (Growth Differentiation Factor 15 (GDF15))
-
Binding Specificity
- AA 30-194, N-Term
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This GDF15 antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), Cell-ELISA (cELISA)
- Purification
- Protein G
- Immunogen
- genetic immunisation with cDNA encoding aa30-194 (N-term) of MIC-1 proprotein
- Clone
- ME-6D10
- Isotype
- IgG1
- Top Product
- Discover our top product GDF15 Primary Antibody
-
-
- Application Notes
-
Flow cytometry: 1.2 µg/10^6 cells
CELISA: 1:200 - 1:400
For each application a titration should be performed to determine the optimal concentration. - Comment
-
Synonyms: GDF15
- Restrictions
- For Research Use only
-
- Buffer
- PBS, pH 7.2
- Handling Advice
- Avoid repeated freezing and thawing.
- Storage
- 4 °C
- Storage Comment
- short term: 2 °C - 8 °C, long term: -20 °C
-
- Target
- GDF15 (Growth Differentiation Factor 15 (GDF15))
- Alternative Name
- MIC-1 (GDF15 Products)
- Background
- Macrophage inhibitory cytokine-1 (MIC-1) is a member of the transforming growth factor-ß superfamily that regulates a wide variety of physiological processes involved in tissue differentiation and maintenance. MIC-1 is synthesized as a 62-kDa intracellular protein, which, after cleavage by a furin like protease, is secreted as a 25-kDa disulphide-linked dimeric protein. Expression of MIC-1 results in inhibition of macrophage activation, regulated by the p53 pathway, in response to pro-inflammatory monokines. MIC-1 is involved in tumour pathogenesis and its measurement can be used as a clinical tool for the diagnosis of a wide range of cancers. It could be a useful marker for aggressive prostate cancer while MIC-1 is upregulated in advanced and more aggressive prostatic tumours.
- UniProt
- Q99988
- Pathways
- SARS-CoV-2 Protein Interactome
-